You have 9 free searches left this month | for more free features.

Hemophagocytic syndrome(HLH)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

    Recruiting
    • Hemophagocytic Syndrome
    • Chongqing, China
      The Second affiliated Hosptial of Chongqing medical University
    Jun 28, 2023

    Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

    Withdrawn
    • Hemophagocytic Lymphohistiocytosis
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytoses
    • +2 more
    • observational
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Dec 22, 2022

    Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

    Recruiting
    • Hemophagocytic Lymphohistiocytoses
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Oct 25, 2022

      EBV Infection Trial in Suzhou (PD-1 mAb)

      Recruiting
      • EBV Infection
      • PD-1 monoclonal antibody
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 1, 2021

      Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

      Not yet recruiting
      • Refractory
      • +2 more
      • GTP regimen
      • (no location specified)
      Sep 8, 2023

      Assessing the Presence of CT-DNA in Lymphoma Associated HLH

      Not yet recruiting
      • Lymphoma
      • Haemophagocytic Lymphohistiocytosis
        • (no location specified)
        Jan 25, 2023

        Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

        Not yet recruiting
        • Haemophagocytic Lymphohistiocytosis
        • (no location specified)
        Feb 28, 2023

        IFN? and Inflammatory Mediators in Hemophagocytic

        Completed
        • Hemophagocytic Lymphohistiocytoses
        • Blood Draws Data Collection
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Sep 14, 2023

        Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

        Not yet recruiting
        • Carbapenem Resistant Bacterial Infection
        • Hemophagocytic Lymphohistiocytoses
        • Carrimycin tablets
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Aug 4, 2023

        Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Lymphoma
        • cytokine
        • Beijing, Beijing, China
          Zhao Wang
        Oct 27, 2022

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Sep 15, 2022

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        Segmental Resection Combined With DEP Regimen for EBV-HLH

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • +2 more
        • Segmental bowel resection combined with the DEP regimen
        • Beijing, Beijing, China
          Zhao Wang
        Nov 9, 2023

        Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • No intervention
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 2, 2023

        HLH Trial in Beijing (Zanubrutinib)

        Recruiting
        • HLH
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 2, 2022

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • L-DEP and PD-1 antibody
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 19, 2022

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
        • DEP combine with PD-1 antibody
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Feb 13, 2022

        Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • Rituximab Monotherapy
        • Beijing, China
          Zhao Wang
        May 18, 2022

        Children and Adult Hemophagocytic Syndrome (HLHa)

        Completed
        • Hemophagocytic Syndrome
        • Identification of biological markers
        • Paris, France
          Clinical Research Unit
        Nov 19, 2021

        Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Cytokine Storm
        • Hangzhou, Zhejiang, China
          The Children's Hospital of Zhejiang University School of Medicin
        Aug 4, 2022

        Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

        Completed
        • Hemophagocytic Lymphohistiocytosis (HLH)
        • Paris, France
          Hôpital Necker-Enfants Malades
        Apr 13, 2021

        HLH Trial in Beijing (Thiotepa)

        Recruiting
        • HLH
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 10, 2023